Comprehensive Pharmacovigilance Analysis of Lebrikizumab: A Real-World Safety Assessment Based on the FDA Adverse Event Reporting System (FAERS) Database

20260 citationsJournal Article

Authors

Maohua Chen · Comprehensive Clinical Research

Yaping Huang · Fujian Provincial Hospital

Abstract

This study provides a comprehensive overview of the safety of lebrikizumab and confirms that it has a favorable and manageable safety profile, supporting its suitability for long-term use in clinical practice.

Topics & Keywords

Pharmacovigilance and Adverse Drug Reactions Drug-Induced Adverse Reactions Antimicrobial Resistance in Staphylococcus

Publication Details

Published in: Immunopharmacology and Immunotoxicology

DOI: 10.1080/08923973.2026.2648209

Field-Weighted Citation Impact: 0.00

Command Palette

Comprehensive Pharmacovigilance Analysis of Lebrikizumab: A Real-World Safety Assessment Based on the FDA Adverse Event Reporting System (FAERS) Database

Authors

Abstract

Topics & Keywords

Publication Details